147 related articles for article (PubMed ID: 30835833)
1. Oncologic outcomes after surgery for locally aggressive basal cell carcinoma of the head and neck.
Gill AS; Nittur VR; Moore MG; Farwell DG; Bewley AF
Laryngoscope; 2020 Jan; 130(1):115-119. PubMed ID: 30835833
[TBL] [Abstract][Full Text] [Related]
2. Multimodality management of high-risk head and neck basal cell carcinoma requiring free-flap reconstruction.
Burch MB; Chung TK; Rosenthal EL; Schmalbach CE
Otolaryngol Head Neck Surg; 2015 May; 152(5):868-73. PubMed ID: 25805638
[TBL] [Abstract][Full Text] [Related]
3. Low recurrence rate of head and neck basal cell carcinoma treated with Mohs micrographic surgery: A retrospective study of 1021 cases.
Kuiper EM; van den Berge BA; Spoo JR; Kuiper J; Terra JB
Clin Otolaryngol; 2018 Oct; 43(5):1321-1327. PubMed ID: 29953746
[TBL] [Abstract][Full Text] [Related]
4. Craniofacial resection for nonmelanoma skin cancer of the head and neck.
Backous DD; DeMonte F; El-Naggar A; Wolf P; Weber RS
Laryngoscope; 2005 Jun; 115(6):931-7. PubMed ID: 15933497
[TBL] [Abstract][Full Text] [Related]
5. Aggressive basal cell carcinoma of the head and neck: challenges in surgical management.
Lohuis PJ; Joshi A; Borggreven PA; Vermeeren L; Zupan-Kajcovski B; Al-Mamgani A; Balm AJ
Eur Arch Otorhinolaryngol; 2016 Nov; 273(11):3881-3889. PubMed ID: 27067586
[TBL] [Abstract][Full Text] [Related]
6. Radiotherapy alone for clinical T4 skin carcinoma of the head and neck with surgery reserved for salvage.
Al-Othman MO; Mendenhall WM; Amdur RJ
Am J Otolaryngol; 2001; 22(6):387-90. PubMed ID: 11713722
[TBL] [Abstract][Full Text] [Related]
7. Non-melanoma skin cancer: United Kingdom National Multidisciplinary Guidelines.
Newlands C; Currie R; Memon A; Whitaker S; Woolford T
J Laryngol Otol; 2016 May; 130(S2):S125-S132. PubMed ID: 27841126
[TBL] [Abstract][Full Text] [Related]
8. Factors Associated with Recurrence and Regional Adenopathy for Head and Neck Cutaneous Squamous Cell Carcinoma.
Harris BN; Bayoumi A; Rao S; Moore MG; Farwell DG; Bewley AF
Otolaryngol Head Neck Surg; 2017 May; 156(5):863-869. PubMed ID: 28322123
[TBL] [Abstract][Full Text] [Related]
9. Basosquamous cell carcinoma: a survey of 76 patients and a comparative analysis of basal cell carcinomas and squamous cell carcinomas.
Betti R; Crosti C; Ghiozzi S; Cerri A; Moneghini L; Menni S
Eur J Dermatol; 2013; 23(1):83-6. PubMed ID: 23238332
[TBL] [Abstract][Full Text] [Related]
10. Mohs micrographic surgery for basal cell carcinomas: results of a Spanish retrospective study and Kaplan–Meier survival analysis of tumour recurrence.
Català A; Garces JR; Alegre M; Gich IJ; Puig L
J Eur Acad Dermatol Venereol; 2014 Oct; 28(10):1363-9. PubMed ID: 25383396
[TBL] [Abstract][Full Text] [Related]
11. Recurrent basal cell carcinoma after incomplete resection.
Robinson JK; Fisher SG
Arch Dermatol; 2000 Nov; 136(11):1318-24. PubMed ID: 11074691
[TBL] [Abstract][Full Text] [Related]
12. Eradication of basal cell carcinoma of the head and neck using the surgical excision with a new stained margin technique: a preliminary study.
Celasco M; Zavattaro E; Veronese F; Boggio P; Bonvini D; Leigheb G; Valente G; Colombo E
G Ital Dermatol Venereol; 2018 Oct; 153(5):624-631. PubMed ID: 28509524
[TBL] [Abstract][Full Text] [Related]
13. The importance of margins in head and neck cancer.
Baddour HM; Magliocca KR; Chen AY
J Surg Oncol; 2016 Mar; 113(3):248-55. PubMed ID: 26960076
[TBL] [Abstract][Full Text] [Related]
14. Factors predictive of recurrence, metastasis, and death from primary basal cell carcinoma 2 cm or larger in diameter.
Morgan FC; Ruiz ES; Karia PS; Besaw RJ; Neel VA; Schmults CD
J Am Acad Dermatol; 2020 Sep; 83(3):832-838. PubMed ID: 31600531
[TBL] [Abstract][Full Text] [Related]
15. Dermatofibrosarcoma protuberans of the head and neck.
Stojadinovic A; Karpoff HM; Antonescu CR; Shah JP; Singh B; Spiro RH; Dumornay W; Shaha AR
Ann Surg Oncol; 2000 Oct; 7(9):696-704. PubMed ID: 11034249
[TBL] [Abstract][Full Text] [Related]
16. Whole specimen intraoperative frozen section analysis. Experience with 1082 basal cell carcinomas.
Kedilioglu MA; Bos PG; De Jong K; Noordzij NA; Kibbelaar RE; Lapid O; Mouës CM
Eur J Surg Oncol; 2018 Jan; 44(1):157-162. PubMed ID: 29198817
[TBL] [Abstract][Full Text] [Related]
17. High recurrence rates of Basal cell carcinoma after mohs surgery in patients with chronic lymphocytic leukemia.
Mehrany K; Weenig RH; Pittelkow MR; Roenigk RK; Otley CC
Arch Dermatol; 2004 Aug; 140(8):985-8. PubMed ID: 15313816
[TBL] [Abstract][Full Text] [Related]
18. Long-term Follow-up of Positive Surgical Margins in Basal Cell Carcinoma of the Face.
Bozan A; Gode S; Kaya I; Yaman B; Uslu M; Akyildiz S; Apaydin F; Ceylan C; Ozturk G
Dermatol Surg; 2015 Jul; 41(7):761-7. PubMed ID: 26050215
[TBL] [Abstract][Full Text] [Related]
19. Long-term recurrence rates of whole specimen intraoperative frozen section analysis in basal cell carcinomas of the face with WIFSA.
Scholten LA; Kedilioglu MA; Huizinga PM; Kibbelaar RE; de Jong K; Mouës CM
J Surg Oncol; 2019 Jun; 119(7):903-908. PubMed ID: 30737791
[TBL] [Abstract][Full Text] [Related]
20. The management of locally advanced head and neck squamous and basal cell carcinomas.
Diamantopoulos P; Deskoulidi P; Dalianoudis I; Farazi Chongouki C; Maltzaris N; Agorogiannis D; Filippou D; Kotrotsiou M; Skandalakis P; Stavrianos S
J BUON; 2018; 23(4):1118-1124. PubMed ID: 30358220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
